Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

Press releases published on April 9, 2026

Apr. 9, 2026

AIM ImmunoTech to Participate in Live Virtual Investor Closing Bell Event

Indeterminate GlobeNewswire

Apr. 9, 2026

Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026

Indeterminate GlobeNewswire

Apr. 9, 2026

Valitor to Participate in the 25th Annual Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire

Apr. 9, 2026

Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples

Indeterminate GlobeNewswire

Apr. 9, 2026

Noom and b.well Partner to Launch Integrated Health Record Access for Medicare Members

Indeterminate GlobeNewswire

Apr. 9, 2026

Zentalis Pharmaceuticals Announces 400mg QD 5:2 Azenosertib Monotherapy as the Pivotal Study Dose in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer

Indeterminate GlobeNewswire

Apr. 9, 2026

Curonix LLC Announces Appointment of Don Payerle to its Board of Managers, Strengthening Strategic Leadership

Indeterminate GlobeNewswire

Apr. 9, 2026

Nexalin Announces Peer-Reviewed Study Showing the Company’s DIFS™ Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents

Indeterminate GlobeNewswire

Apr. 9, 2026

Smith+Nephew’s REGENETEN◊ Bioinductive Implant shows post-operative recovery times halved, and high healing rates for partial-thickness rotator cuff tears1,*

Indeterminate GlobeNewswire

Apr. 9, 2026

AMN Healthcare to Hold First Quarter 2026 Earnings Conference Call on Thursday, May 7, 2026

Indeterminate GlobeNewswire

Apr. 9, 2026

Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026

Indeterminate GlobeNewswire

Apr. 9, 2026

Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline

Indeterminate GlobeNewswire

Apr. 9, 2026

InflaRx Reports New Mechanistic Data for Izicopan Supporting its Potential as a Best-in-Class C5aR Inhibitor

Indeterminate GlobeNewswire

Apr. 9, 2026

Weight Watchers Announces Board Committee Appointments

Indeterminate GlobeNewswire

Apr. 9, 2026

Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles

Indeterminate GlobeNewswire

Apr. 9, 2026

Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th  

Indeterminate GlobeNewswire

Apr. 9, 2026

Oxford BioTherapeutics Enters Strategic Collaboration with Bristol Myers Squibb to Discover and Develop Next-Generation T-cell Engagers for Solid Tumours

Indeterminate GlobeNewswire

Apr. 9, 2026

Soleo Health Opens New Ambulatory Infusion Center in Austin, Texas

Indeterminate GlobeNewswire

Apr. 9, 2026

Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy

Indeterminate GlobeNewswire

Apr. 9, 2026

Satellos to Present at the Bloom Burton & Co. Healthcare Investor Conference

Indeterminate GlobeNewswire